Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000904454-16-001373
Filing Date
2016-08-18
Accepted
2016-08-18 17:11:34
Documents
1
Period of Report
2016-08-16

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 12915
  Complete submission text file 0000904454-16-001373.txt   15373
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Reporting) CIK: 0000200406 (see all company filings)

State of Incorp.: NJ | Fiscal Year End: 0101
Type: 4 | Act: 34 | File No.: 001-37852 | Film No.: 161841507
SIC: 2834 Pharmaceutical Preparations

Mailing Address 410 GEORGE STREET NEW BRUNSWICK NJ 08901
Business Address 410 GEORGE STREET NEW BRUNSWICK NJ 08901 (732) 524-3218
Johnson & Johnson Innovation - JJDC, Inc. (Reporting) CIK: 0000924020 (see all company filings)

State of Incorp.: NJ
Type: 4 | Act: 34 | File No.: 001-37852 | Film No.: 161841506

Mailing Address 521 COTTONWOOD DRIVE, SUITE 100 MALPITAS CA 95035-7404
Business Address 521 COTTONWOOD DRIVE, SUITE 100 MALPITAS CA 95035-7404 408-649-7370
Protagonist Therapeutics, Inc (Issuer) CIK: 0001377121 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations